Two years of smoking cessation does not reduce arterial wall thickness and stiffness

F W P J van den Berkmortel1, H Wollersheim, H van Langen

  • 1Department of Medicine, Division of General Internal Medicine, University Medical Centre, St Radboud, PO Box 9101, 6500 HB Nijmegen, the Netherlands. f.vandenberkmortel@onco.umcn.nl

Insights

Smoking cessation rapidly lowers cardiovascular risk, but arterial wall changes like intima-media thickness and distensibility are not significantly improved after two years. Continued smoking cessation is still recommended for its proven cardiovascular benefits.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Public Health

Background:

  • Smoking cessation is known to rapidly reduce cardiovascular risk.
  • The underlying pathophysiological mechanisms are not fully understood.
  • Arterial wall properties may play a role in cardiovascular risk reduction post-cessation.

Purpose of the Study:

  • To measure structural and functional arterial wall properties after smoking cessation.
  • To investigate the role of arterial properties in cardiovascular risk reduction.
  • To compare changes in arterial properties between former smokers, current smokers, and non-smokers.

Main Methods:

  • Prospective study comparing 33 two-year quitters, 55 persistent smokers, and 50 non-smokers.
  • Ultrasonographic measurement of cross-sectional compliance, distensibility coefficients, and intima-media thickness.
  • Measurements taken at baseline and 3, 6, 12, and 24 months post-cessation.

Main Results:

  • Two years of smoking cessation did not alter cross-sectional compliance or distensibility coefficients.
  • Intima-media thickness changes over time did not significantly differ between groups.
  • Baseline intima-media thickness was greater in smokers compared to non-smokers.

Conclusions:

  • Two years of smoking cessation did not lead to regression or slower progression of intima-media thickness.
  • Improved arterial compliance or distensibility was not observed after two years of cessation.
  • Despite no observed arterial structural changes, smoking cessation is strongly recommended for rapid cardiovascular risk reduction.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...